Prostate cancer screening is an ever-changing field because the benefits of using PSA as a screening tool is not clear-cut, subsequently causing a lack of standardization of screening protocols among various providers. In 2012, the USPSTF published their recommendation of grade D to prostate cancer screening, which caused a decrease in its use. However, the USPSTF recently changed their recommendation from grade D to C, conceding that screening can be beneficial to a certain group of people. Patients are understandably confused about what is appropriate for them; now is the perfect time to raise awareness about the importance of prostate cancer screening and to motivate patients to start a shared-decision making conversation with their provider.https://scholarworks.uvm.edu/fmclerk/1315/thumbnail.jp
